Volume 3; Issue 1

Breast Cancer Research

Volume 3; Issue 1
4

VIII International Congress of the Metastasis Research Society

Year:
2000
Language:
english
File:
PDF, 100 KB
english, 2000
10

Breast imaging technology: Current and future technologies for breast cancer imaging

Year:
2000
Language:
english
File:
PDF, 412 KB
english, 2000
11

BRCA1function in T lymphocytes: a cellular specificity of a different kind

Year:
2000
Language:
english
File:
PDF, 81 KB
english, 2000
12

Whither high-dose chemotherapy in breast cancer?

Year:
2000
Language:
english
File:
PDF, 82 KB
english, 2000
13

Syk: a new player in the field of breast cancer

Year:
2000
Language:
english
File:
PDF, 85 KB
english, 2000
14

The mammary myoepithelial cell - Cinderella or ugly sister?

Year:
2000
Language:
english
File:
PDF, 108 KB
english, 2000
15

Estrogen receptor β in breast cancer

Year:
2000
Language:
english
File:
PDF, 67 KB
english, 2000
16

Tamoxifen and angiogenesis

Year:
2000
Language:
english
File:
PDF, 83 KB
english, 2000
17

Marker of increased cancer risk in benign breast disease

Year:
2000
Language:
english
File:
PDF, 51 KB
english, 2000
18

Microdissection and microarrays

Year:
2000
Language:
english
File:
PDF, 59 KB
english, 2000
19

Chromosome 6 alterations

Year:
2000
Language:
english
File:
PDF, 60 KB
english, 2000
20

APCgene mutations in human breast cancers

Year:
2000
Language:
english
File:
PDF, 60 KB
english, 2000
21

HOXA5 regulation of p53 in breast tumours

Year:
2000
Language:
english
File:
PDF, 61 KB
english, 2000
23

ER variants in breast cancer

Year:
2000
Language:
english
File:
PDF, 86 KB
english, 2000
24

Pathologic features associated with nonsentinel lymph node metastasis

Year:
2000
Language:
english
File:
PDF, 60 KB
english, 2000
25

c-erbB2 homodimerisation in mammary epithelial cells

Year:
2000
Language:
english
File:
PDF, 62 KB
english, 2000
26

Nuclear cytometric changes in breast carcinogenesis

Year:
2000
Language:
english
File:
PDF, 61 KB
english, 2000
27

Tailored versus high-dose chemotherapy as adjuvant breast cancer treatment

Year:
2000
Language:
english
File:
PDF, 64 KB
english, 2000
28

Enhanced activity of anti-Lewisyhumanised 3S193 when combined with Taxol

Year:
2000
Language:
english
File:
PDF, 54 KB
english, 2000
29

Ang1 in breast cancer

Year:
2000
Language:
english
File:
PDF, 63 KB
english, 2000
30

An anti-oncogenic role for decorin

Year:
2000
Language:
english
File:
PDF, 94 KB
english, 2000
31

Tamoxifen, angiogenesis, oestrogens and animal models

Year:
2000
Language:
english
File:
PDF, 61 KB
english, 2000
32

The effect of BRK on EGF signalling viaerbB3 in mammary epithelial cells

Year:
2000
Language:
english
File:
PDF, 87 KB
english, 2000
33

Prognosis and treatment of small breast carcinomas

Year:
2000
Language:
english
File:
PDF, 82 KB
english, 2000
34

Tissue microarray validation

Year:
2000
Language:
english
File:
PDF, 77 KB
english, 2000
35

Normal mammary epithelial cells escape of senescence

Year:
2000
Language:
english
File:
PDF, 62 KB
english, 2000
36

Response to CMF according to HER-2 overexpression

Year:
2000
Language:
english
File:
PDF, 83 KB
english, 2000
37

Comparison of different methods of HER-2 analysis in archival tissue

Year:
2000
Language:
english
File:
PDF, 86 KB
english, 2000
38

Liposome-encapsulated doxorubicin in metastatic breast cancer

Year:
2000
Language:
english
File:
PDF, 80 KB
english, 2000
39

Phase III trial of chemotherapy ? HerceptinR in metastatic breast cancer

Year:
2000
Language:
english
File:
PDF, 60 KB
english, 2000
40

Comparison of DCIS and post-surgical local recurrence

Year:
2000
Language:
english
File:
PDF, 96 KB
english, 2000
41

Nuclear-cytoplasmic shuttling of p21Cip1/WAF1is regulated by Akt

Year:
2000
Language:
english
File:
PDF, 61 KB
english, 2000
42

Endocrine response: IsCGAthe key?

Year:
2000
Language:
english
File:
PDF, 59 KB
english, 2000
43

Anin vitrobreast cell immortalisation assay

Year:
2000
Language:
english
File:
PDF, 85 KB
english, 2000
44

What doDictyosteliumand mammary gland have in common?

Year:
2000
Language:
english
File:
PDF, 64 KB
english, 2000
45

Carbonic anhydrase expression in DCIS

Year:
2000
Language:
english
File:
PDF, 62 KB
english, 2000
46

ER? expression seems important in preinvasive cancers

Year:
2000
Language:
english
File:
PDF, 60 KB
english, 2000
47

Duration of adjuvant tamoxifen treatment

Year:
2000
Language:
english
File:
PDF, 82 KB
english, 2000
48

Is E-cadherin/catenin axis important in grade III ductal carcinomas?

Year:
2000
Language:
english
File:
PDF, 79 KB
english, 2000
49

Breast cell interactions within a 3D model culture system

Year:
2000
Language:
english
File:
PDF, 82 KB
english, 2000
50

Cyclin D1in breast cancer is not associated with Ki67 but with ER

Year:
2000
Language:
english
File:
PDF, 89 KB
english, 2000
51

Multigene expression patterns predict metastatic behavior

Year:
2000
Language:
english
File:
PDF, 61 KB
english, 2000
52

Activin can activate p38 MAPK

Year:
2000
Language:
english
File:
PDF, 50 KB
english, 2000
53

GW5638: a new antiestrogen

Year:
2000
Language:
english
File:
PDF, 51 KB
english, 2000
54

Her-2/neu expression in primary breast cancer and its lymph node metastases

Year:
2000
Language:
english
File:
PDF, 82 KB
english, 2000
55

Her-2/neuandtopoisomerase IIaexpression in primary and metastatic breast cancer

Year:
2000
Language:
english
File:
PDF, 64 KB
english, 2000
56

Membrane oestrogen receptor

Year:
2000
Language:
english
File:
PDF, 78 KB
english, 2000
57

EGF receptor: new trick for an old dog?

Year:
2000
Language:
english
File:
PDF, 51 KB
english, 2000
58

Iressa inhibits growth of HER-2-overexpressing cells

Year:
2000
Language:
english
File:
PDF, 59 KB
english, 2000
59

Dual HER-2/EGFR tyrosine kinase inhibitors

Year:
2000
Language:
english
File:
PDF, 61 KB
english, 2000
60

Breast cancer protection: hormonal priming via p53?

Year:
2000
Language:
english
File:
PDF, 60 KB
english, 2000